[ASND] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
29-Aug-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -49.13%
YoY- -0.27%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 3,211 5,414 10,515 20 18 28 280 410.81%
PBT -58,969 -53,707 -32,066 -34,067 -22,876 -41,482 -34,361 43.48%
Tax -65 -70 -88 -100 -99 -107 -186 -50.48%
NP -58,904 -53,637 -31,978 -33,967 -22,777 -41,375 -34,175 43.89%
Tax Rate - - - - - - - -
Total Cost 62,115 59,051 42,493 33,987 22,795 41,403 34,455 48.28%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -1,834.44 -990.71 -304.12 -169,835.00 -126,538.89 -147,767.86 -12,205.36 -71.82%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -1.25 -1.24 -0.76 -0.81 -0.55 -1.07 -0.92 22.74%
EPS Diluted -1.25 -1.24 -0.74 -0.81 -0.55 -1.07 -0.88 26.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.